Volume 206, Issue 4 | Psychopharmacology

Search all Psychopharmacology articles

Volume 206, Issue 4

November 2009

Special Issue on Modelling Psychosis

17 articles in this issue

Modelling psychosis
H. Valerie Curran
Deepak Cyril D’Souza
Paul Fletcher
Editorial 16 September 2009 Pages: 513 - 514
From drugs to deprivation: a Bayesian framework for understanding models of psychosis
P. R. Corlett
C. D. Frith
P. C. Fletcher
Review Open access 28 May 2009 Pages: 515 - 530
Role of cannabis and endocannabinoids in the genesis of schizophrenia
Emilio Fernandez-Espejo
Maria-Paz Viveros
Fernando Rodriguez de Fonseca
Review 24 July 2009 Pages: 531 - 549
The endocannabinoid system as a target for modelling psychosis
Dagmar Koethe
Carolin Hoyer
F. Markus Leweke
Review 16 June 2009 Pages: 551 - 561
Superstitious conditioning as a model of delusion formation following chronic but not acute ketamine in humans
Tom P. Freeman
Celia J. A. Morgan
H. Valerie Curran
Original Investigation 13 May 2009 Pages: 563 - 573
Modeling “psychosis” in vitro by inducing disordered neuronal network activity in cortical brain slices
George K. Aghajanian
Review Open access 25 February 2009 Pages: 575 - 585
Prenatal exposure to infection: a primary mechanism for abnormal dopaminergic development in schizophrenia
Urs Meyer
Joram Feldon
Review 11 March 2009 Pages: 587 - 602
The amphetamine sensitization model of schizophrenia: relevance beyond psychotic symptoms?
Daria Peleg-Raibstein
Benjamin K. Yee
Jonas Hauser
Review 27 March 2009 Pages: 603 - 621
Long-term effects of neonatal MK-801 treatment on prepulse inhibition in young adult rats
Takashi Uehara
Tomiki Sumiyoshi
Masayoshi Kurachi
Original Investigation 16 April 2009 Pages: 623 - 630
Reversal of cognitive deficits by an ampakine (CX516) and sertindole in two animal models of schizophrenia—sub-chronic and early postnatal PCP treatment in attentional set-shifting
Brian Villumsen Broberg
Birte Yding Glenthøj
Christina Kurre Olsen
Original Investigation 24 April 2009 Pages: 631 - 640
Combined administration of an mGlu2/3 receptor agonist and a 5-HT_2A receptor antagonist markedly attenuate the psychomotor-activating and neurochemical effects of psychostimulants
Jason M. Uslaner
Sean M. Smith
Pete H. Hutson
Original Investigation 26 August 2009 Pages: 641 - 651
Cognitive effects of psychotomimetic drugs in rats discriminating number cues
C. B. Willmore
D. M. Krall
G. I. Elmer
Original Investigation 09 October 2008 Pages: 653 - 664
Serotonergic lesions of the dorsal hippocampus differentially modulate locomotor hyperactivity induced by drugs of abuse in rats: implications for schizophrenia
Wendy Adams
Scott Ayton
Maarten van den Buuse
Original Investigation 23 July 2009 Pages: 665 - 676
Are DBA/2 mice associated with schizophrenia-like endophenotypes? A behavioural contrast with C57BL/6 mice
Philipp Singer
Joram Feldon
Benjamin K. Yee
Original Investigation 30 May 2009 Pages: 677 - 698
Asenapine effects in animal models of psychosis and cognitive function
Hugh M. Marston
Jared W. Young
Mohammed Shahid
Original Investigation Open access 22 May 2009 Pages: 699 - 714
The d-amphetamine-treated Göttingen miniature pig: an animal model for assessing behavioral effects of antipsychotics
F. Josef van der Staay
Bruno Pouzet
Teun Schuurman
Original Investigation Open access 23 July 2009 Pages: 715 - 729
Disruption of latent inhibition induced by ovariectomy can be reversed by estradiol and clozapine as well as by co-administration of haloperidol with estradiol but not by haloperidol alone
Michal Arad
Ina Weiner
Original Investigation 25 January 2009 Pages: 731 - 740